David Michael Johnson - 28 Oct 2021 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Director
Signature
/s/ Julie Feder
Issuer symbol
AURA
Transactions as of
28 Oct 2021
Net transactions value
$0
Form type
4
Filing time
29 Oct 2021, 19:33:19 UTC
Previous filing
04 Oct 2021
Next filing
02 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURA Stock Option (Right to Buy) Award $0 +24,000 $0.000000 24,000 28 Oct 2021 Common Stock 24,000 $14.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest as follows: These shares will vest in full on October 28, 2022.